Your browser doesn't support javascript.
loading
Sudden cardiac death after heart transplantation: a population-based study.
Bonnet, Guillaume; Coutance, Guillaume; Aubert, Olivier; Waldmann, Victor; Raynaud, Marc; Asselin, Anouk; Bories, Marie-Cécile; Guillemain, Romain; Bruneval, Patrick; Varnous, Shaida; Leprince, Pascal; Achouch, Paul; Marijon, Eloi; Loupy, Alexandre; Jouven, Xavier.
Afiliación
  • Bonnet G; Université de Paris, Paris Cardiovascular Research Center (PARCC), Paris Translational Research Center for Organ Transplantation, INSERM, UMR-S970, 75015 Paris, France.
  • Coutance G; UMCV, Haut-Lévêque Hospital, University Hospital of Bordeaux, 33600 Pessac, France.
  • Aubert O; Université de Paris, Paris Cardiovascular Research Center (PARCC), Paris Translational Research Center for Organ Transplantation, INSERM, UMR-S970, 75015 Paris, France.
  • Waldmann V; Department of Cardiac and Thoracic Surgery, Cardiology Institute, Pitié-Salpeêtrière Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Sorbonne University Medical School, Paris, France.
  • Raynaud M; Université de Paris, Paris Cardiovascular Research Center (PARCC), Paris Translational Research Center for Organ Transplantation, INSERM, UMR-S970, 75015 Paris, France.
  • Asselin A; Kidney Transplant Department, Necker Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Bories MC; Université de Paris, Paris Cardiovascular Research Center (PARCC), Paris Translational Research Center for Organ Transplantation, INSERM, UMR-S970, 75015 Paris, France.
  • Guillemain R; Cardiology and Heart Transplant department, European Georges Pompidou Hospital, Assistance Publique-Hôpitaux de Paris, Rue Leblanc, 75015 Paris, France.
  • Bruneval P; Université de Paris, Paris Cardiovascular Research Center (PARCC), Paris Translational Research Center for Organ Transplantation, INSERM, UMR-S970, 75015 Paris, France.
  • Varnous S; Université de Paris, Paris Cardiovascular Research Center (PARCC), Paris Translational Research Center for Organ Transplantation, INSERM, UMR-S970, 75015 Paris, France.
  • Leprince P; Cardiology and Heart Transplant department, European Georges Pompidou Hospital, Assistance Publique-Hôpitaux de Paris, Rue Leblanc, 75015 Paris, France.
  • Achouch P; Cardiology and Heart Transplant department, European Georges Pompidou Hospital, Assistance Publique-Hôpitaux de Paris, Rue Leblanc, 75015 Paris, France.
  • Marijon E; Pathology Department, Georges Pompidou Hospital, Assistance Publique-Hôpitaux de Paris. Université de Paris, Paris, France.
  • Loupy A; Department of Cardiac and Thoracic Surgery, Cardiology Institute, Pitié-Salpeêtrière Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Sorbonne University Medical School, Paris, France.
  • Jouven X; INSERM, UMRS-1166, iCAN, Institute of Cardiometabolism and Nutrition, Hôpital de la Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Université Pierre et Marie Curie, Paris, France.
Europace ; 25(5)2023 05 19.
Article en En | MEDLINE | ID: mdl-37208303
ABSTRACT

AIMS:

The epidemiology of sudden cardiac death (SCD) after heart transplantation (HTx) remains imprecisely described. We aimed to assess the incidence and determinants of SCD in a large cohort of HTx recipients, compared with the general population. METHODS AND

RESULTS:

Consecutive HTx recipients (n = 1246, 2 centres) transplanted between 2004 and 2016 were included. We prospectively assessed clinical, biological, pathologic, and functional parameters. SCD was centrally adjudicated. We compared the SCD incidence beyond the first year post-transplant in this cohort with that observed in the general population of the same geographic area (registry carried out by the same group of investigators; n = 19 706 SCD). We performed a competing risk multivariate Cox model to identify variables associated with SCD. The annual incidence of SCD was 12.5 per 1,000 person-years [95% confidence interval (CI), 9.7-15.9] in the HTx recipients cohort compared with 0.54 per 1,000 person-years (95% CI, 0.53-0.55) in the general population (P < 0.001). The risk of SCD was markedly elevated among the youngest HTx recipients with standardized mortality ratios for SCD up to 837 for recipients ≤30 years. Beyond the first year, SCD was the leading cause of death. Five variables were independently associated with SCD older donor age (P = 0.003), younger recipient age (P = 0.001) and ethnicity (P = 0.034), pre-existing donor-specific antibodies (P = 0.009), and last left ventricular ejection fraction (P = 0.048).

CONCLUSION:

HTx recipients, particularly the youngest, were at very high risk of SCD compared with the general population. The consideration of specific risk factors may help identify high-risk subgroups.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Función Ventricular Izquierda / Trasplante de Corazón Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Europace Asunto de la revista: CARDIOLOGIA / FISIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Función Ventricular Izquierda / Trasplante de Corazón Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Europace Asunto de la revista: CARDIOLOGIA / FISIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Francia